Literature DB >> 24669958

Agonists for the adenosine A1 receptor with tunable residence time. A Case for nonribose 4-amino-6-aryl-5-cyano-2-thiopyrimidines.

Julien Louvel1, Dong Guo, Marta Agliardi, Tamara A M Mocking, Roland Kars, Tan Phát Pham, Lizi Xia, Henk de Vries, Johannes Brussee, Laura H Heitman, Adriaan P Ijzerman.   

Abstract

We report the synthesis and evaluation of previously unreported 4-amino-6-aryl-5-cyano-2-thiopyrimidines as selective human adenosine A1 receptor (hA1AR) agonists with tunable binding kinetics, this without affecting their nanomolar affinity for the target receptor. They show a very diverse range of kinetic profiles (from 1 min (compound 52) to 1 h (compound 43)), and their structure-affinity relationships (SAR) and structure-kinetics relationships (SKR) were established. When put in perspective with the increasing importance of binding kinetics in drug discovery, these results bring new evidence of the consequences of affinity-only driven selection of drug candidates, that is, the potential elimination of slightly less active compounds that may display preferable binding kinetics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24669958     DOI: 10.1021/jm401643m

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

1.  Molecular docking screening using agonist-bound GPCR structures: probing the A2A adenosine receptor.

Authors:  David Rodríguez; Zhang-Guo Gao; Steven M Moss; Kenneth A Jacobson; Jens Carlsson
Journal:  J Chem Inf Model       Date:  2015-02-13       Impact factor: 4.956

2.  A kinetic view of GPCR allostery and biased agonism.

Authors:  J Robert Lane; Lauren T May; Robert G Parton; Patrick M Sexton; Arthur Christopoulos
Journal:  Nat Chem Biol       Date:  2017-08-18       Impact factor: 15.040

3.  Discovery of Highly Potent Adenosine A1 Receptor Agonists: Targeting Positron Emission Tomography Probes.

Authors:  Min Guo; Abolghasem Bakhoda; Zhan-Guo Gao; Joseph M Ramsey; Yang Li; Kelly A O'Conor; Andrew C Kelleher; Seth M Eisenberg; Yeona Kang; Xuefeng Yan; Cameron Javdan; Joanna S Fowler; Kenner C Rice; Jacob M Hooker; Kenneth A Jacobson; Sung Won Kim; Nora D Volkow
Journal:  ACS Chem Neurosci       Date:  2021-09-01       Impact factor: 5.780

4.  Preclinical Evaluation of the First Adenosine A1 Receptor Partial Agonist Radioligand for Positron Emission Tomography Imaging.

Authors:  Min Guo; Zhan-Guo Gao; Ryan Tyler; Tyler Stodden; Yang Li; Joseph Ramsey; Wen-Jing Zhao; Gene-Jack Wang; Corinde E Wiers; Joanna S Fowler; Kenner C Rice; Kenneth A Jacobson; Sung Won Kim; Nora D Volkow
Journal:  J Med Chem       Date:  2018-11-13       Impact factor: 7.446

5.  Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: Adenosine receptor binding and potent PDE4 inhibition.

Authors:  Zafer Sahin; Sevde Nur Biltekin; Leyla Yurttas; Barkin Berk; Yağmur Özhan; Hande Sipahi; Zhan-Guo Gao; Kenneth A Jacobson; Şeref Demirayak
Journal:  Eur J Med Chem       Date:  2020-12-31       Impact factor: 6.514

6.  Prolonged and tunable residence time using reversible covalent kinase inhibitors.

Authors:  J Michael Bradshaw; Jesse M McFarland; Ville O Paavilainen; Angelina Bisconte; Danny Tam; Vernon T Phan; Sergei Romanov; David Finkle; Jin Shu; Vaishali Patel; Tony Ton; Xiaoyan Li; David G Loughhead; Philip A Nunn; Dane E Karr; Mary E Gerritsen; Jens Oliver Funk; Timothy D Owens; Erik Verner; Ken A Brameld; Ronald J Hill; David M Goldstein; Jack Taunton
Journal:  Nat Chem Biol       Date:  2015-05-25       Impact factor: 15.040

7.  TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy.

Authors:  Barbara Costa; Eleonora Da Pozzo; Chiara Giacomelli; Elisabetta Barresi; Sabrina Taliani; Federico Da Settimo; Claudia Martini
Journal:  Sci Rep       Date:  2016-01-11       Impact factor: 4.379

Review 8.  Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development.

Authors:  Chrisna Matthee; Gisella Terre'Blanche; Lesetja J Legoabe; Helena D Janse van Rensburg
Journal:  Mol Divers       Date:  2021-06-27       Impact factor: 3.364

9.  Measurement of Ligand-Target Residence Times by 1H Relaxation Dispersion NMR Spectroscopy.

Authors:  Thomas Moschen; Sarina Grutsch; Michael A Juen; Christoph H Wunderlich; Christoph Kreutz; Martin Tollinger
Journal:  J Med Chem       Date:  2016-11-29       Impact factor: 7.446

10.  Structure-Affinity Relationships and Structure-Kinetic Relationships of 1,2-Diarylimidazol-4-carboxamide Derivatives as Human Cannabinoid 1 Receptor Antagonists.

Authors:  Lizi Xia; Henk de Vries; Eelke B Lenselink; Julien Louvel; Michael J Waring; Leifeng Cheng; Sara Pahlén; Maria J Petersson; Peter Schell; Roine I Olsson; Laura H Heitman; Robert J Sheppard; Adriaan P IJzerman
Journal:  J Med Chem       Date:  2017-11-21       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.